| Units | First LP ever | Follow-up LPs, first LP/event |
---|---|---|---|
Pleocytosis, all acute attacks | Samples | 41/70 (58.6%) | 4/11 (36.4%) |
Pleocytosis, acute MY | Samples | 21/25 (84%) | 1/2 (50%) |
Pleocytosis, acute ON | Samples | 4/21 (19%) | 1/4 (25%) |
Pleocytosis, acute BRAIN | Samples | 16/24 (66.7%) | 2/5 (40%) |
OCB, all acute attacks | Samples | 8/67 (11.9%) | 1/12 (8.3%) |
OCB, acute MY | Samples | 6/25 (24%) | 1/2 (50%)a |
OCB, acute ON | Samples | 0/21 (0%) | 0/5 (0%) |
OCB, acute BRAIN | Samples | 2/21 (9.5%) | 0/5 (0%) |
IgG-IF > 10%, all acute attacks | Samples | 4/53 (7.5%) | 6/12 (50%) |
IgG-IF > 10%, acute MY | Samples | 2/20 (10%) | 1/1 (100%) |
IgG-IF > 10%, acute ON | Samples | 0/18 (0%) | 0/1 (0%) |
IgG-IF > 10%, acute BRAIN | Samples | 2/15 (13.3%) | 0/5 (0%) |
QAlb > Qlim(Alb), all acute attacks | Samples | 28/56 (50%) | 3/8 (37.5%) |
QAlb > Qlim(Alb), acute MY | Samples | 14/21 (66.7%) | 0/1 (0%) |
QAlb > Qlim(Alb), acute ON | Samples | 3/18 (16.7%) | 2/2 (100%) |
QAlb > Qlim(Alb), acute BRAIN | Samples | 11/17 (64.7%) | 1/5 (20%) |
CSF TP elevated, all acute attacks | Samples | 16/66 (24.2%) | 2/11 (18.2%) |
CSF TP elevated, acute MY | Samples | 9/23 (39.1%) | 1/2 (50%) |
CSF TP elevated, acute ON | Samples | 1/20 (5%) | 0/4 (0%) |
CSF TP elevated, acute BRAIN | Samples | 6/23 (26.1%) | 1/5 (20%) |
CSF l-lactate elevated, all acute attacks | Samples | 17/49 (34.7%) | 2/10 (20%) |
CSF l-lactate elevated, acute MY | Samples | 9/18 (50%) | 1/2 (50%) |
CSF l-lactate elevated, acute ON | Samples | 2/16 (12.5%) | 1/4 (25%) |
CSF l-lactate elevated, acute BRAIN | Samples | 6/15 (40%) | 0/4 (0%) |
Time since attack onset, acute LPs | Days | 2 (0–33) | 4.5 (0–40) |